Cardiac evaluation of the liver transplant candidate.
Journal
Current opinion in organ transplantation
ISSN: 1531-7013
Titre abrégé: Curr Opin Organ Transplant
Pays: United States
ID NLM: 9717388
Informations de publication
Date de publication:
24 Nov 2023
24 Nov 2023
Historique:
pubmed:
23
11
2023
medline:
23
11
2023
entrez:
23
11
2023
Statut:
aheadofprint
Résumé
This review aims to summarize recent changes in the cardiac evaluation of adult liver transplant candidates. Over the last several years, there have been significant advances in the use of coronary computed tomography angiography (CCTA) with and without fractional flow reserve (FFR) and increasingly widespread availability of coronary calcium scoring for risk stratification for obstructive coronary artery disease. This has led to novel strategies for risk stratification in cirrhotic patients being considered for liver transplant and an updated American Heart Association (AHA) position paper on the evaluation of liver and kidney transplant candidates. The diagnosis of cirrhotic cardiomyopathy has been refined. These new diagnostic criteria require that specific echocardiographic parameters are evaluated in all patients. The definition of pulmonary hypertension on echocardiography has been altered and no longer utilizes right atrium (RA) pressure estimates based on inferior vena cava (IVC) size and collapse. This provides more volume neutral estimates of pulmonary pressure. Although CCTA has outstanding negative predictive value, false positive results are not uncommon and often lead to further testing. Revised diagnostic criteria for cirrhotic cardiomyopathy improve risk stratification for peri-operative volume overload and outcomes. Refined pulmonary hypertension criteria provide improved guidance for right heart catheterization (RHC) and referral to subspecialists. There are emerging data regarding the safety and efficacy of TAVR for severe aortic stenosis in cirrhotic patients. Increased utilization of noninvasive testing, including CCTA and/or coronary calcium scoring, can improve the negative predictive value of testing for obstructive coronary artery disease and potentially reduce reliance on coronary angiography. Application of the 2020 criteria for cirrhotic cardiomyopathy will improve systolic and diastolic function assessment and subsequent perioperative risk stratification. The use of global strain scores is emphasized, as it provides important information beyond ejection fraction and diastolic parameters. A standardized one-parameter echo cut-off for elevated pulmonary pressures simplifies both evaluation and follow-up. Innovative transcutaneous techniques for valvular stenosis and regurgitation offer new options for patients at prohibitive surgical risk.
Identifiants
pubmed: 37995156
doi: 10.1097/MOT.0000000000001122
pii: 00075200-990000000-00099
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Wong RJ, Singal AK. Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Netw Open 2020; 3:e1920294.
VanWagner LB, Serper M, Kang R, et al. Factors associated with major adverse cardiovascular events after liver transplantation among a national sample. Am J Transplant 2016; 16:2684–2694.
Carey WD, Dumot JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59:859–864.
Lee BC, Li F, Hanje AJ, et al. Effectively screening for coronary artery disease in patients undergoing orthotopic liver transplant evaluation. J Transplant 2016; 2016:7187206.
Patel SS, Lin FP, Rodriguez VA, et al. The relationship between coronary artery disease and cardiovascular events early after liver transplantation. Liver Int 2019; 39:1363–1371.
Soldera J, Camazzola F, Rodriguez S, Brandao A. Cardiac stress testing and coronary artery disease in liver transplantation candidates: meta-analysis. World J Hepatol 2018; 10:877–886.
Sharma V, Kleb C, Sheth C, et al. Cardiac considerations in liver transplantation. Cleve Clin J Med 2022; 89:46–55.
Bhatti S, Lizaola-Mayo B, Al-Shoha M, et al. Use of computed tomography coronary calcium score for coronary artery disease risk stratification during liver transplant evaluation. J Clin Exp Hepatol 2022; 12:319–328.
Hughes DL, Pan J, Answine AR, et al. Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of postliver transplant major adverse cardiac events. Liver Transpl 2023; 29:970–978.
Konerman MA, Fritze D, Weinberg RL, et al. Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review. Transplantation 2017; 101:1645–1657.
Safadi A, Homsi M, Maskoun W, et al. Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009; 120:1189–1194.
Kutkut I, Rachwan RJ, Timsina LR, et al. Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality. Hepatology 2020; 72:240–256.
Cheng XS, VanWagner LB, Costa SP, et al. Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American Heart Association: endorsed by the American Society of Transplantation. Circulation 2022; 146:e299–e324.
Izzy M, VanWagner LB, Lin G, et al. Redefining cirrhotic cardiomyopathy for the modern era. Hepatology 2020; 71:334–345.
Dowsley TF, Bayne DB, Langnas AN, et al. Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation. Transplantation 2012; 94:646–651.
Jansen C, Schroder A, Schueler R, et al. Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt. Hepatol Commun 2019; 3:340–347.
Isaak A, Praktiknjo M, Jansen C, et al. Myocardial fibrosis and inflammation in liver cirrhosis: MRI Study of the Liver-Heart Axis. Radiology 2020; 297:51–61.
Kim HM, Kim HK, Lee JH, et al. Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study. J Cardiovasc Magn Reson 2020; 22:25.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79:e263–e421.
Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991; 100:520–528.
D’Alto M, Di Maio M, Romeo E, et al. Echocardiographic probability of pulmonary hypertension: a validation study. Eur Respir J 2022; 60:2102548.
Martin P, DiMartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014; 59:1144–1165.
Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53:1–13.
Ma X, Zhao D, Li J, Wei D, et al. Transcatheter aortic valve implantation in the patients with chronic liver disease: a mini-review and meta-analysis. Medicine (Baltimore) 2020; 99:e19766.
Bushyhead D, Kirkpatrick JN, Goldberg D. Pretransplant echocardiographic parameters as markers of posttransplant outcomes in liver transplant recipients. Liver Transpl 2016; 22:316–323.
Ahmed T, Misumida N, Grigorian A, et al. Transcatheter interventions for valvular heart diseases in liver cirrhosis patients. Trends Cardiovasc Med 2023; 33:242–249.
Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014; 64:182–192.
Al-Bawardy R, Vemulapalli S, Thourani VH, et al. Association of pulmonary hypertension with clinical outcomes of transcatheter mitral valve repair. JAMA Cardiol 2020; 5:47–56.
Gundling F, Schmidtler F, Zelihic E, et al. [Frequency of cardiac arrhythmia in patients with liver cirrhoses and evaluation of associated factors]. Z Gastroenterol 2012; 50:1149–1155.
Lewin SM, Kallianos K, Nevah MI, et al. Cardiac MRI T2∗ in liver transplant candidates: application and performance of a novel imaging technique to identify patients at risk for poor posttransplant cardiac outcomes. Transplant Direct 2018; 4:e363.
Wang C, Gao H, Sun J, et al. Cardiac involvement in Wilson's disease: a retrospective cohort study. Eur J Gastroenterol Hepatol 2022; 34:1147–1150.